You just read:

Angionetics' Generx® [Ad5FGF-4] Gene Therapy Biologic Receives FDA Clearance For U.S. Phase 3 Clinical Study As A New, Single Dose, Treatment For Coronary Artery Disease

News provided by

Taxus Cardium Pharmaceuticals Group Inc.

Sep 12, 2016, 09:00 ET